Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome.

by Ila R Singh, John E Gorzynski, Daria Drobysheva, Leda Bassit, Raymond F Schinazi
Published 2010-04-01